Potent cellular and humoral immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use

समान संसाधन

• Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity
  द्वारा: Gudmundsdotter, Lindvi, और अन्य
  प्रकाशित: (2009)
• Potent Functional Antibody Responses Elicited by HIV-I DNA Priming and Boosting with Heterologous HIV-1 Recombinant MVA in Healthy Tanzanian Adults
  द्वारा: Joachim, Agricola, और अन्य
  प्रकाशित: (2015)
• Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR Boost
  द्वारा: Joachim, Agricola, और अन्य
  प्रकाशित: (2020)
• Broad Immunogenicity of a Multigene, Multiclade HIV-1 DNA Vaccine Boosted with Heterologous HIV-1 Recombinant Modified Vaccinia Virus Ankara
  द्वारा: Sandström, Eric, और अन्य
  प्रकाशित: (2008)
• Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania(,)
  द्वारा: Bakari, Muhammad, और अन्य
  प्रकाशित: (2011)